BIOMAT Database Logo BIOMAT Database Logo

[Immunosuppressive therapy using cytostatics]. 1971

K Schumacher, and D Ricken

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007112 Immunity, Maternally-Acquired Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Fetal Immunity, Maternally-Acquired,Maternally-Acquired Immunity,Neonatal Immunity, Maternally-Acquired,Immunity, Maternally Acquired,Fetal Immunities, Maternally-Acquired,Fetal Immunity, Maternally Acquired,Immunity, Maternally-Acquired Fetal,Immunity, Maternally-Acquired Neonatal,Maternally Acquired Immunities,Maternally Acquired Immunity,Maternally-Acquired Fetal Immunities,Maternally-Acquired Fetal Immunity,Maternally-Acquired Immunities,Maternally-Acquired Neonatal Immunities,Maternally-Acquired Neonatal Immunity,Neonatal Immunities, Maternally-Acquired,Neonatal Immunity, Maternally Acquired
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

K Schumacher, and D Ricken
[Immunosuppressive therapy (cytostatics) in glomerulonephritis].
January 1972, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
K Schumacher, and D Ricken
[Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents)].
March 1970, Munchener medizinische Wochenschrift (1950),
K Schumacher, and D Ricken
[Immunosuppressive effect of cytostatics].
May 1980, Problemy gematologii i perelivaniia krovi,
K Schumacher, and D Ricken
[Treatment of dermatologic lesions using immunosuppressive agents and cytostatics].
March 1970, Munchener medizinische Wochenschrift (1950),
K Schumacher, and D Ricken
[Clinical pharmacology of immunosuppressive cytostatics].
November 1970, Nordisk medicin,
K Schumacher, and D Ricken
[Complications of immunosuppressive therapy using cytostatics in autoaggression diseases with special reference to cholestatic hepatosis].
June 1973, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
K Schumacher, and D Ricken
[Experience in using immunosuppressive-cytostatics in the treatment of psoriasis].
September 1974, Vestnik dermatologii i venerologii,
K Schumacher, and D Ricken
[Cytostatics and immunosuppressive agents in dermatology].
September 1970, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
K Schumacher, and D Ricken
[Immunosuppressive effect of cytostatics in the clinic].
July 1970, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
K Schumacher, and D Ricken
[Therapy using cytostatics. Desired and undesired effects].
November 1973, Fortschritte der Medizin,
Copied contents to your clipboard!